(Q37656243)

21 August 2017

1 reference

title

Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy (English)

1 reference

21 August 2017

main subject

Pseudomonas aeruginosa

0 references

Acinetobacter baumannii

1 reference

based on heuristic

inferred from title

multiple drug resistance

1 reference

based on heuristic

inferred from title

author

Renata Cristina Picão

series ordinal

3

object named as

Renata C Picão

1 reference

21 August 2017

4

Ana C Gales

1 reference

21 August 2017

Alexandre P Zavascki

1

1 reference

21 August 2017

Cecília G Carvalhaes

series ordinal

2

1 reference

21 August 2017

publication date

1 January 2010

1 reference

Expert Review of Anti-infective Therapy

21 August 2017

published in

1 reference

21 August 2017

volume

8

1 reference

21 August 2017

issue

1

1 reference

21 August 2017

page(s)

71-93

1 reference

Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Treatment of Pseudomonas aeruginosa infection in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Acinetobacter baumannii: emergence of a successful pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Attributable mortality of Acinetobacter baumannii: no longer a controversial issue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

What is in the pipeline for Gram-negative pathogens?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

A step closer to extreme drug resistance (XDR) in gram-negative bacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

A functional classification scheme for beta-lactamases and its correlation with molecular structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

The structure of β-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Extended-spectrum cephalosporinases in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 beta-lactamase: defining a unique family of class C enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Cytosolic intermediates for cell wall biosynthesis and degradation control inducible beta-lactam resistance in gram-negative bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Model system to evaluate the effect of ampD mutations on AmpC-mediated beta-lactam resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Sequences of the NPS-1 and TLE-1 beta-lactamase genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Pseudomonas aeruginosa - a phenomenon of bacterial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Identification of the novel narrow-spectrum beta-lactamase SCO-1 in Acinetobacter spp. from Argentina

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Genetic and biochemical characterization of the first extended-spectrum CARB-type beta-lactamase, RTG-4, from Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Defining an extended-spectrum beta-lactamase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Ambler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Further identification of CTX-M-2 extended-spectrum beta-lactamase in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

GES-11, a novel integron-associated GES variant in Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Biochemical characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa 802.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

A Pseudomonas aeruginosa isolate producing the GES-5 extended-spectrum beta-lactamase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Molecular detection of GES-2 extended spectrum Beta-lactamase producing Pseudomonas aeruginosa in Pretoria, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Extended-spectrum beta-lactamases: a clinical update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Detection of the novel extended-spectrum beta-lactamase OXA-161 from a plasmid-located integron in Pseudomonas aeruginosa clinical isolates from Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Carbapenemases: molecular diversity and clinical consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Biochemical characterization of the naturally occurring oxacillinase OXA-50 of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

OXA (beta)-lactamases in Acinetobacter: the story so far.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Eleven novel OXA-51-like enzymes from clinical isolates of Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

High prevalence of OXA-51-type class D beta-lactamases among ceftazidime-resistant clinical isolates of Acinetobacter spp.: co-existence with OXA-58 in multiple centres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

In vivo selection of reduced susceptibility to carbapenems in Acinetobacter baumannii related to ISAba1-mediated overexpression of the natural bla(OXA-66) oxacillinase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Emerging carbapenemases in Gram-negative aerobes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Extended -10 promoter in ISAba-1 upstream of blaOXA-23 from Acinetobacter baumannii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Clinically significant carbapenemases: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Acinetobacter radioresistens as a silent source of carbapenem resistance for Acinetobacter spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Codetection of blaOXA-23-like gene (blaOXA-133) and blaOXA-58 in Acinetobacter radioresistens: report from the SENTRY antimicrobial surveillance program

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

First detection of the OXA-40 carbapenemase in P. aeruginosa isolates, located on a plasmid also found in A. baumannii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Surveillance of carbapenem-resistant Pseudomonas aeruginosa isolates from Puerto Rican Medical Center Hospitals: dissemination of KPC and IMP-18 beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

KPC-2-producing Enterobacter cloacae and pseudomonas putida coinfection in a liver transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Molecular characterization of a beta-lactamase gene, blaGIM-1, encoding a new subclass of metallo-beta-lactamase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Novel acquired metallo-beta-lactamase gene, bla(SIM-1), in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Aminoglycosides versus bacteria--a description of the action, resistance mechanism, and nosocomial battleground.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Aminoglycoside resistance in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Molecular epidemiology of aminoglycoside resistance in Acinetobacter spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Efflux-mediated antimicrobial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Efflux pumps as antimicrobial resistance mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Role of outer membrane protein OprD and penicillin-binding proteins in resistance of Pseudomonas aeruginosa to imipenem and meropenem

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Alterations of susceptibility of Pseudomonas aeruginosa by overproduction of multidrug efflux systems, MexAB-OprM, MexCD-OprJ, and MexXY/OprM to carbapenems: substrate specificities of the efflux systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Function of pseudomonas porins in uptake and efflux.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Of Pseudomonas, porins, pumps and carbapenems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Decreases of the susceptibility to low molecular weight beta-lactam antibiotics in imipenem-resistant Pseudomonas aeruginosa mutants: role of outer membrane protein D2 in their diffusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Contribution of the MexXY Multidrug Transporter to Aminoglycoside Resistance in Pseudomonas aeruginosa Clinical Isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

The amino terminus of Pseudomonas aeruginosa outer membrane protein OprF forms channels in lipid bilayer membranes: correlation with a three-dimensional model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Molecular and structural characterization of the HMP-AB gene encoding a pore-forming protein from a clinical isolate of Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Loss of a 29-kilodalton outer membrane protein in Acinetobacter baumannii is associated with imipenem resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Acquisition of resistance to carbapenems in multidrug-resistant clinical strains of Acinetobacter baumannii: natural insertional inactivation of a gene encoding a member of a novel family of beta-barrel outer membrane proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Comparative genomics of multidrug resistance in Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Independent emergence of colistin-resistant Acinetobacter spp. isolates from Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Citywide emergence of Pseudomonas aeruginosa strains with reduced susceptibility to polymyxin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Polymyxin-resistant Acinetobacter spp. isolates: what is next?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Contribution of the PhoP-PhoQ and PmrA-PmrB two-component regulatory systems to Mg2+-induced gene regulation in Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Involvement of pmrAB and phoPQ in polymyxin B adaptation and inducible resistance in non-cystic fibrosis clinical isolates of Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Colistin heteroresistance in acinetobacter and its association with previous colistin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Timing and dynamics of single cell gene expression in the arabinose utilization system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Stress and the single cell: intrapopulation diversity is a mechanism to ensure survival upon exposure to stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Microbial cell individuality and the underlying sources of heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Comparison of cefepime, cefpirome, and cefaclidine binding affinities for penicillin-binding proteins in Escherichia coli K-12 and Pseudomonas aeruginosa SC8329

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Comparative analysis of Pseudomonas aeruginosa penicillin-binding protein 7 in the context of its membership in the family of low-molecular-mass PBPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Function of penicillin-binding protein 2 in viability and morphology of Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

beta-Lactam-resistant Pseudomonas aeruginosa with modified penicillin-binding proteins emerging during cystic fibrosis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Imipenem resistance in Acinetobacter baumanii is due to altered penicillin-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Evaluation of SDS-polyacrylamide gel systems for the study of outer membrane protein profiles of clinical strains of Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts during an outbreak of Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Novel gyrA and parC point mutations in two strains of Acinetobacter baumannii resistant to ciprofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

AbeM, an H+-coupled Acinetobacter baumannii multidrug efflux pump belonging to the MATE family of transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

First report of qnrB-producing Enterobacter cloacae and qnrA-producing Acinetobacter baumannii recovered from Algerian hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Molecular understanding of aminoglycoside action and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Intravenous colistimethate for multidrug-resistant Gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Establishing the role of tigecycline in an era of antimicrobial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

The new treatment paradigm and the role of carbapenems

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Carbapenemases: the versatile beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Setting and revising antibacterial susceptibility breakpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

A long journey from minimum inhibitory concentration testing to clinically predictive breakpoints: deterministic and probabilistic approaches in deriving breakpoints.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Metallo-beta-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Pharmacokinetics of polymyxin B1 in patients with multidrug-resistant Gram-negative bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Pharmacokinetics of intravenous polymyxin B in critically ill patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Activity of colistin against heteroresistant Acinetobacter baumannii and emergence of resistance in an in vitro pharmacokinetic/pharmacodynamic model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Stable polymyxin B susceptibility to Pseudomonas aeruginosa and Acinetobacter spp. despite persistent recovery of these organisms from respiratory secretions of patients with ventilator-associated pneumonia treated with this drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Treatment options for multidrug-resistant bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

A review of tigecycline--the first glycylcycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Influence of testing methodology on the tigecycline activity profile against presumably tigecycline-non-susceptible Acinetobacter spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Susceptibility testing of tigecycline against Acinetobacter spp. by disc diffusion method: withdrawing a therapeutic option by varying the Mueller-Hinton agar?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Effect of medium age and supplementation with the biocatalytic oxygen-reducing reagent oxyrase on in vitro activities of tigecycline against recent clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Effect of medium type, age and aeration on the MICs of tigecycline and classical tetracyclines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Tigecycline MIC testing by broth dilution requires use of fresh medium or addition of the biocatalytic oxygen-reducing reagent oxyrase to standardize the test method

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

High concentrations of manganese in Mueller-Hinton agar increase MICs of tigecycline determined by Etest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Tigecycline pharmacokinetic/pharmacodynamic update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Tigecycline possibly underdosed for the treatment of pneumonia: a pharmacokinetic viewpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Steady-state serum and intrapulmonary pharmacokinetics and pharmacodynamics of tigecycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Treatment of recurrent urosepsis with tigecycline: a pharmacological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Pharmacokinetic considerations regarding tigecycline for multidrug-resistant (MDR) Klebsiella pneumoniae or MDR Acinetobacter baumannii urosepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Cefepime: a reappraisal in an era of increasing antimicrobial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Failure of current cefepime breakpoints to predict clinical outcomes of bacteremia caused by gram-negative organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Piperacillin-tazobactam: a beta-lactam/beta-lactamase inhibitor combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Outcomes of bacteremia due to Pseudomonas aeruginosa with reduced susceptibility to piperacillin-tazobactam: implications on the appropriateness of the resistance breakpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Pharmacokinetics of aztreonam in healthy subjects and patients with cystic fibrosis and evaluation of dose-exposure relationships using monte carlo simulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Rational antibiotic therapy and the position of ampicillin/sulbactam

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Sulbactam-containing beta-lactamase inhibitor combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Ampicillin/sulbactam: current status in severe bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Antimicrobial susceptibility testing of Acinetobacter spp. by NCCLS broth microdilution and disk diffusion methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Combination antimicrobial treatment versus monotherapy: the contribution of meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Detection of SHV-1 beta-lactamase in Pseudomonas aeruginosa strains by genetic methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Spread of bla(CTX-M-type) and bla(PER-2) beta-lactamase genes in clinical isolates from Bolivian hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Detection of extended-spectrum beta-lactamases in clinical isolates of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

A CTX-M extended-spectrum beta-lactamase in Pseudomonas aeruginosa and Stenotrophomonas maltophilia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

OXA-46, a new class D beta-lactamase of narrow substrate specificity encoded by a blaVIM-1-containing integron from a Pseudomonas aeruginosa clinical isolate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Outbreak by meropenem-resistant Pseudomonas aeruginosa producing IMP-6 metallo-beta-lactamase in a Korean hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Detection of a variant metallo-beta-lactamase, IMP-10, from two unrelated strains of Pseudomonas aeruginosa and an alcaligenes xylosoxidans strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

IMP-12, a new plasmid-encoded metallo-beta-lactamase from a Pseudomonas putida clinical isolate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Integron carrying a novel metallo-beta-lactamase gene, blaIMP-16, and a fused form of aminoglycoside-resistant gene aac(6')-30/aac(6')-Ib': report from the SENTRY Antimicrobial Surveillance Program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

First organisms with acquired metallo-beta-lactamases (IMP-13, IMP-22, and VIM-2) reported in Austria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

IMP-1 and a novel metallo-beta-lactamase, VIM-6, in fluorescent pseudomonads isolated in Singapore

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Molecular epidemiology of outbreak-related pseudomonas aeruginosa strains carrying the novel variant blaVIM-17 metallo-beta-lactamase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Carbapenem resistance among Pseudomonas aeruginosa strains from India: evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Molecular characterization of SPM-1, a novel metallo-beta-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Emergence of PER-2 and VEB-1a in Acinetobacter baumannii Strains in the Americas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Dissemination of multidrug-resistant, class 1 integron-carrying Acinetobacter baumannii isolates in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Widespread transfer of resistance genes between bacterial species in an intensive care unit: implications for hospital epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Nosocomial transmission of CTX-M-2 beta-lactamase-producing Acinetobacter baumannii in a neurosurgery ward

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Nucleotide sequence of the bla(RTG-2) (CARB-5) gene and phylogeny of a new group of carbenicillinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Chromosomal integration of a cephalosporinase gene from Acinetobacter baumannii into Oligella urethralis as a source of acquired resistance to beta-lactams

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

[Dissemination of IMP-1 and OXA type beta-lactamase in carbapenem-resistant Acinetobacter baumannii].

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Outbreak of Acinetobacter baumannii producing the carbapenem-hydrolyzing oxacillinase OXA-58 in Rome, Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Molecular characterization of metallo-beta-lactamase-producing Acinetobacter baumannii and Acinetobacter genomospecies 3 from Korea: identification of two new integrons carrying the bla(VIM-2) gene cassettes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Molecular characterisation of the metallo-beta-lactamase genes in imipenem-resistant Gram-negative bacteria from a university hospital in southern Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Overexpression of the MexEF-OprN multidrug efflux system affects cell-to-cell signaling in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Genetic elements carrying macrolide efflux genes in streptococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Contributions of MexAB-OprM and an EmrE homolog to intrinsic resistance of Pseudomonas aeruginosa to aminoglycosides and dyes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

The Pseudomonas aeruginosa tonB gene encodes a novel TonB protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Identification of an OprD homologue in Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Comparison of the pharmacodynamics of imipenem in patients with ventilator-associated pneumonia following administration by 2 or 0.5 h infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Population pharmacokinetics of high-dose, prolonged-infusion cefepime in adult critically ill patients with ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

Optimal dosing of piperacillin-tazobactam for the treatment of Pseudomonas aeruginosa infections: prolonged or continuous infusion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus–Acinetobacter baumannii complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.108

21 January 2018

Identifiers

DOI

10.1586/ERI.09.108

1 reference

21 August 2017

1 reference